--- title: Buy Metaglip (Glipizide/Metformin) 2.5/500mg | 5/500mg Pills description: Metaglip (Glipizide and Metformin HCl) 2.5/500mg or 5/500mg controls blood sugar in type 2 diabetes. Order securely from our pharmacy for verified quality. type: product language: en url: https://liabilis.com/order-metaglip-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 35.99 price_max: 107.99 currency: USD offers: - name: 2.5/500mg x 30 pills price: 35.99 - name: 2.5/500mg x 60 pills price: 53.99 - name: 2.5/500mg x 120 pills price: 59.99 - name: 2.5/500mg x 90 pills price: 62.99 - name: 2.5/500mg x 180 pills price: 71.99 - name: 5/500mg x 30 pills price: 44.99 - name: 5/500mg x 60 pills price: 59.99 - name: 5/500mg x 90 pills price: 80.99 - name: 5/500mg x 120 pills price: 102.99 - name: 5/500mg x 180 pills price: 107.99 --- # Buy Metaglip (Glipizide/Metformin) 2.5/500mg | 5/500mg Pills Metaglip, combining Glipizide and Metformin Hydrochloride and developed by Bristol-Myers Squibb, is an oral antidiabetic for adults with type 2 diabetes to improve glycemic control. It works through complementary mechanisms. Available in 2.5/500mg or 5/500mg pills from our reliable online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **2.5/500mg** | 30 pills | **$35.99** | $1.20 | In Stock | | **2.5/500mg** | 60 pills | **$53.99** | $0.90 | In Stock | | **2.5/500mg** | 120 pills | **$59.99** | $0.50 | In Stock | | **2.5/500mg** | 90 pills | **$62.99** | $0.70 | In Stock | | **2.5/500mg** | 180 pills | **$71.99** | $0.40 | In Stock | | **5/500mg** | 30 pills | **$44.99** | $1.50 | In Stock | | **5/500mg** | 60 pills | **$59.99** | $1.00 | In Stock | | **5/500mg** | 90 pills | **$80.99** | $0.90 | In Stock | | **5/500mg** | 120 pills | **$102.99** | $0.86 | In Stock | | **5/500mg** | 180 pills | **$107.99** | $0.60 | In Stock | [Buy Now](https://liabilis.com/order-metaglip-online-en.html) ## Introduction Metaglip is a generic oral antihyperglycaemic tablet that combines two well-established agents: glipizide, a sulfonylurea that stimulates insulin release, and metformin hydrochloride, which decreases hepatic glucose production and improves peripheral insulin sensitivity. The medication is supplied as a pill in fixed-dose strengths of 2.5 mg glipizide/500 mg metformin and 5 mg glipizide/500 mg metformin. It belongs to the therapeutic class of combination oral glucose-lowering agents and is primarily used in adults with type 2 diabetes mellitus when monotherapy does not achieve glycaemic targets. ## Quick Reference Facts **Active Ingredient** : Glipizide and Metformin Hydrochloride **Form** : pill 2.5/500 mg | 5/500 mg **Primary and Off-Label Uses** : • Management of type 2 diabetes mellitus (primary) : • Occasionally used in combination with other agents for patients with inadequate control on metformin alone (off-label) ## What is Metaglip? Metaglip is the generic version of medications that contain the active compounds glipizide and metformin hydrochloride. It provides the same clinical effect as brand-name fixed-dose combinations of a sulfonylurea with metformin, which are marketed under brand names such as Glucovance® and other sulfonylurea-metformin products. As a generic, Metaglip is bioequivalent to those branded formulations, offering comparable efficacy, safety, and pharmacokinetic profiles at a lower cost. The product is manufactured by licensed pharmaceutical firms that meet international Good Manufacturing Practice (GMP) standards, although specific manufacturer details are not disclosed in publicly available sources. ## How Metaglip Works Glipizide belongs to the sulfonylurea class; it binds to the sulfonylurea receptor on pancreatic β-cells, leading to closure of ATP-sensitive potassium channels. This depolarises the cell membrane, triggers calcium influx, and promotes insulin secretion independent of ambient glucose levels. Metformin hydrochloride, a biguanide, primarily inhibits hepatic gluconeogenesis via activation of AMP-activated protein kinase (AMPK). It also enhances peripheral glucose uptake by improving insulin signalling in muscle and adipose tissue. By pairing an insulin secretagogue with an insulin sensitiser, Metaglip simultaneously raises endogenous insulin availability and reduces hepatic glucose output, producing a complementary reduction in fasting and post-prandial blood glucose. The onset of glipizide-mediated insulin release occurs within 30-60 minutes, while metformin’s effect on hepatic glucose production begins within a few hours and persists for the dosing interval. Both agents are excreted unchanged in the urine (glipizide) or as metabolites (metformin), with minimal hepatic metabolism, allowing predictable dosing in patients with normal renal function. ## Conditions Treated with Metaglip - **Type 2 Diabetes Mellitus** - Fixed-dose therapy addresses hyperglycaemia when metformin alone is insufficient, improving HbA1c by 1-1.5 % in clinical studies of sulfonylurea-metformin combinations. - **Adjunct to Diet and Exercise** - When lifestyle measures fail to achieve target glycaemic control, Metaglip provides pharmacologic support without the need for multiple separate pills. - **Secondary Failure on Monotherapy** - Patients who experience loss of efficacy on metformin monotherapy often regain glycaemic control after adding a sulfonylurea; the combination simplifies this step. ## Is Metaglip the Right Medication for You? Metaglip is appropriate for adult patients with type 2 diabetes whose HbA1c remains above goal despite maximally tolerated metformin. It is particularly useful when a single-tablet regimen is preferred for adherence. Patients with preserved renal function (eGFR ≥ 60 mL/min/1.73 m²) are good candidates, as both components are renally eliminated. Contraindications include known hypersensitivity to sulfonylureas or metformin, severe renal impairment (eGFR < 30 mL/min), acute or chronic metabolic acidosis, and pregnancy. Caution is advised in the elderly, those with a history of cardiovascular disease, or individuals taking drugs that may potentiate hypoglycaemia. Clinicians should assess liver function, cardiac status, and concomitant medications before initiating therapy. ## Buying Metaglip from [our online pharmacy](https://liabilis.com/order-metaglip-online-en.html) ### Why Choose Our Service? [our online pharmacy](https://liabilis.com/order-metaglip-online-en.html) delivers affordable access to Metaglip for patients who encounter cost barriers or limited local stock. By sourcing directly from accredited international suppliers, we help you obtain the medication without compromising quality. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch is verified against regulatory standards before shipment. ### Pricing & Access Because Metaglip is a generic formulation, it is offered at a price close to wholesale cost, substantially lower than branded equivalents. This makes long-term diabetes management more financially sustainable. ### Discreet Delivery Orders are packaged in unmarked, tamper-evident envelopes and dispatched via express delivery (typically within 7 days) or standard airmail (approximately 3 weeks), protecting your privacy throughout the process. ## Use: Dosing, Missed Dose, Overdose **Standard Dosing** - Initiate with 2.5 mg glipizide/500 mg metformin once daily with breakfast. - If glycaemic control is insufficient after 2 weeks, the dose may be increased to 5 mg glipizide/500 mg metformin once daily, provided renal function is adequate. **Missed Dose** - If you miss a dose and the next scheduled dose is more than 8 hours away, take the missed tablet with the next meal. - Do **not** double the dose to compensate for the missed tablet. **Suspected Overdose** - Symptoms may include severe hypoglycaemia (sweating, tremor, confusion) and gastrointestinal upset from excess metformin. - Seek immediate medical attention; treatment may involve glucose administration and monitoring of lactate levels. **Practical Precautions** - Take Metaglip with food to reduce gastrointestinal discomfort. - Avoid excessive alcohol, which can heighten the risk of lactic acidosis from metformin. - Use caution when operating machinery or driving until you know how the medication affects you. ## Safety Information ### ⚠️ Who Should Not Take Metaglip - Individuals with a documented allergy to sulfonylureas or metformin. - Patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²). - Those with acute or chronic metabolic acidosis, including diabetic ketoacidosis. - Pregnant or breastfeeding women (risk to the fetus and infant). ### Common Side Effects - **Hypoglycaemia** - More common when meals are skipped or excessive alcohol is consumed; usually mild to moderate. - **Gastrointestinal upset** - Nausea, abdominal discomfort, or diarrhoea, particularly during the first weeks of therapy. - **Weight gain** - Attributable to the sulfonylurea component stimulating insulin. ### Serious Side Effects (Seek Immediate Medical Help) - **Lactic acidosis** - Rare but life-threatening; symptoms include rapid breathing, muscle pain, and abdominal discomfort. - **Severe hypoglycaemia** - Manifested by loss of consciousness, seizures, or inability to awaken. - **Allergic reactions** - Swelling of the face, lips, tongue, or throat, and difficulty breathing. ### Drug & Food Interactions - **CYP2C9 inhibitors** (e.g., fluconazole, amiodarone) may increase glipizide plasma levels, heightening hypoglycaemia risk. - **Contrast media** used in imaging can impair renal function transiently; metformin should be discontinued before and after the procedure according to guidelines. - **Beta-blockers** may mask typical hypoglycaemia warning signs such as tachycardia. - **Thiazide diuretics** can potentiate hyperglycaemic effects of sulfonylureas; monitor blood glucose closely. ## Off-Label and Investigational Uses of Metaglip Some clinicians prescribe Metaglip in patients with gestational diabetes when oral therapy is required after dietary measures fail, although this use is not approved by regulatory agencies and must be supervised by an obstetrician-endocrinologist. Small pilot studies have explored the combination for polycystic ovary syndrome (PCOS) to improve insulin resistance, but evidence remains limited. Off-label use should only occur under direct medical supervision, with careful monitoring for hypoglycaemia and metabolic side effects. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place, protected from light and moisture. - Keep the container tightly closed and out of reach of children. - Do not use after the expiry date printed on the label; discard any unused tablets according to local pharmacy waste guidelines. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Metaglip?** Yes, but keep the medication in its original packaging with a copy of the prescription or a physician’s letter, as some countries require documentation for import of antihyperglycaemic agents. - **Will eating a high-protein breakfast affect Metaglip’s action?** A balanced meal containing protein, carbohydrates, and fat can moderate the post-prandial glucose rise and may reduce the risk of sulfonylurea-induced hypoglycaemia. - **Is it safe to exercise after taking Metaglip?** Moderate exercise is encouraged; however, intense or prolonged activity may increase insulin sensitivity and heighten hypoglycaemia risk. Monitor glucose before, during, and after exercise. **Product & Formulation Details** - **What do Metaglip tablets look like?** The 2.5 mg/500 mg strength is a white, biconvex tablet imprinted with “2.5/500”. The 5 mg/500 mg strength is similar in shape but marked “5/500”. - **Can the tablets be split?** The tablets are not scored; splitting may lead to dose inaccuracy and should be avoided. - **Are there any inactive ingredients of concern?** Common excipients include microcrystalline cellulose, magnesium stearate, and lactose. Patients with lactose intolerance should consult a pharmacist, although the amount is typically negligible. **Regulatory & Safety Nuances** - **Will Metaglip appear on a sports drug test?** Neither glipizide nor metformin is listed on the World Anti-Doping Agency (WADA) prohibited substance list; routine testing should not flag these agents. - **Is Metaglip approved for use in the elderly?** The medication can be used in older adults, but dose initiation at the lower 2.5 mg/500 mg strength and careful titration are recommended due to increased hypoglycaemia susceptibility. - **Can I purchase Metaglip without a prescription?** In most jurisdictions, Metaglip is a prescription-only medication. Our pharmacy requires a valid prescription from a licensed practitioner before dispensing. **Scientific & Clinical Curiosity** - **What major clinical trial supported the sulfonylurea-metformin combination?** Large randomized controlled trials, such as the UKPDS (United Kingdom Prospective Diabetes Study), demonstrated that adding a sulfonylurea to metformin significantly improved glycaemic control and reduced microvascular complications. - **How does the bioavailability of glipizide compare to other sulfonylureas?** Glipizide has a high oral bioavailability (~90 %) and a relatively short half-life (2-4 hours), allowing once-daily dosing when combined with metformin. ## Glossary **Sulfonylurea** : A class of oral diabetes drugs that stimulate pancreatic insulin release by closing ATP-sensitive potassium channels in β-cells. **Metformin** : A biguanide that lowers blood glucose chiefly by inhibiting hepatic gluconeogenesis and enhancing peripheral insulin sensitivity. **Hypoglycaemia** : Abnormally low blood glucose levels, typically < 70 mg/dL, which can cause symptoms ranging from shakiness to loss of consciousness. **eGFR (estimated Glomerular Filtration Rate)** : A calculated measure of kidney function used to adjust dosing of renally excreted medications. **Lactic Acidosis** : A rare but serious metabolic disturbance characterized by elevated blood lactate and low pH, most often associated with metformin accumulation in renal impairment. ## Disclaimer The information provided about **Metaglip** is intended for general educational purposes and does not replace personalized medical advice. Treatment choices, including any off-label applications, should be made under the guidance of a qualified healthcare professional. Readers are presumed to be adults capable of making informed health decisions. [our online pharmacy](https://liabilis.com/order-metaglip-online-en.html) makes Metaglip available to individuals who may encounter limited access or high costs through conventional channels, including those seeking generic alternatives. Always discuss any medication changes with your physician before starting, modifying, or stopping therapy.